How to get Wellbutrin fast in California

If you’re struggling with Binge Eating Disorder (BED), you’ve likely wondered: Can I get treatment through telehealth? The short answer is yes—and in many ways, telehealth has made evidence-based BED treatment more accessible than ever before.

Whether you’re considering medications like Topamax (topiramate) or Wellbutrin (bupropion), or you’re simply exploring your options, this comprehensive guide will walk you through everything you need to know about getting BED medication through telehealth in 2025, including the legal landscape, what to expect during your evaluation, and how to ensure you’re receiving safe, quality care.

Understanding Binge Eating Disorder and Telehealth Treatment

Binge Eating Disorder is the most common eating disorder in the United States, affecting millions of people who experience recurrent episodes of eating large amounts of food while feeling a loss of control. According to DSM-5 criteria, BED involves eating an unusually large amount within a two-hour period, feeling unable to stop, and experiencing this at least once weekly for three months—without the compensatory purging behaviors seen in bulimia.

The good news? Telehealth has opened new pathways to evidence-based treatment that were previously difficult to access, especially for those in rural areas, those with mobility challenges, or individuals who felt ashamed seeking in-person care for an eating disorder.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The Legal Landscape: Can Providers Actually Prescribe BED Medications Online?

Federal Rules: The Ryan Haight Act Doesn’t Apply Here

One of the most important things to understand is that non-controlled medications like Topamax and Wellbutrin are NOT subject to the strict federal telehealth prescribing restrictions that apply to controlled substances like ADHD stimulants or opioids.

The Ryan Haight Act, passed in 2008, created in-person examination requirements for controlled substance prescriptions via telehealth. However, this law was designed specifically for DEA-scheduled drugs and does not apply to non-controlled medications. This means that for BED medications like topiramate and bupropion, there has never been a federal barrier to telehealth prescribing.

While the DEA has extended COVID-era flexibilities for controlled substance prescribing through December 31, 2026, these extensions primarily affect medications like Adderall or Vyvanse. For the non-controlled medications commonly used in BED treatment, telehealth prescribing has remained fully legal and accessible throughout 2025 and beyond.

State-by-State Variations: What You Need to Know

While federal law is permissive for non-controlled medications, individual states set their own telehealth standards. Here’s what the landscape looks like across the U.S.:

States with No In-Person Requirements:The majority of states—including California, New York, Texas, Florida, Delaware, Michigan, Wisconsin, and South Carolina—allow providers to prescribe non-controlled medications like Topamax and Wellbutrin entirely via telehealth, with no mandatory in-person visit.

California even went a step further in 2025 with AB 1503, redefining what constitutes a ‘good faith exam’ to explicitly include asynchronous telehealth evaluations (online questionnaires and secure messaging), making BED treatment more accessible than ever.

States Requiring Periodic In-Person Follow-Up:A handful of states—notably Alabama, Georgia, and New Hampshire—require that patients receiving ongoing telehealth treatment have at least one in-person examination within a 12-month period.

In Alabama, if you’ve had more than four telehealth visits for the same condition within 12 months, an in-person visit with any qualified provider becomes necessary. Georgia requires providers to ‘attempt’ an annual in-person exam for continued telemedicine care. New Hampshire’s 2025 legislation (SB 252) modernized telehealth rules but maintained an annual in-person follow-up requirement.

Important caveat: These in-person requirements can often be satisfied by seeing any healthcare provider in your state—not necessarily your telehealth prescriber. This means you could maintain your primary telehealth relationship while fulfilling state requirements through an annual physical with a local doctor.

Who Can Prescribe BED Medications via Telehealth?

Physicians and Advanced Practice Providers

Medical Doctors (MDs) and Doctors of Osteopathy (DOs) can prescribe Topamax and Wellbutrin for BED via telehealth in all 50 states, provided they hold a valid license in your state.

Nurse Practitioners (NPs) and Physician Assistants (PAs) can also prescribe these medications, though the level of autonomy varies significantly by state:

Full Practice Authority States (34 states + DC): In states like California, New York, Delaware, Michigan, Wisconsin, and New Hampshire, NPs can practice completely independently, evaluating patients and prescribing BED medications without physician oversight. Recent legislative victories in 2025 expanded this list—Wisconsin and Michigan both granted full practice authority to NPs through new laws that took effect in August 2025.

Collaborative Practice States: In states like Texas, Florida, Georgia, and Alabama, NPs and PAs must work under collaborative agreements with physicians. This doesn’t typically affect your care experience—you’ll still receive quality treatment—but it’s a regulatory requirement that operates behind the scenes.

What This Means for You: At Klarity Health, our network includes both independent practitioners and collaborative teams depending on your state’s requirements, ensuring you have access to qualified providers regardless of where you live. Our transparent approach means you’ll know exactly who’s prescribing your medication and their credentials before your first appointment.

Medications Commonly Prescribed for BED via Telehealth

Topamax (Topiramate)

Classification: Non-controlled prescription medication
FDA Approval: Seizure disorders and migraine prevention (BED use is off-label)
Telehealth Availability: ✅ Legal in all 50 states via telehealth

Topiramate is frequently prescribed off-label for Binge Eating Disorder based on clinical evidence showing it can reduce binge frequency and help with impulse control. Research suggests it may work by affecting neurotransmitters involved in appetite regulation and reward processing.

Key Considerations:

• Titration Required: Providers typically start with low doses (25mg) and gradually increase to minimize side effects like tingling sensations or cognitive changes
• Pregnancy Warning: Topiramate is linked to increased risk of cleft palate and other birth defects. Your provider will discuss contraception if you’re of childbearing potential
• Common Monitoring: Weight, metabolic panels, cognitive function, and mood changes
• Typical Supply: 90-day prescriptions with refills are common

Wellbutrin (Bupropion)

Classification: Non-controlled prescription medication
FDA Approval: Depression and smoking cessation (BED use is off-label)
Telehealth Availability: ✅ Legal in all 50 states via telehealth

Bupropion has shown promise in reducing binge eating episodes in clinical studies, particularly for individuals who also experience depression or emotional eating patterns. It works differently than most antidepressants, affecting dopamine and norepinephrine rather than serotonin.

Key Considerations:

• Black Box Warning: Like all antidepressants, carries a warning about increased suicide risk in people under 25—your provider will monitor you closely, especially when starting treatment
• Contraindications: Cannot be used if you have a history of bulimia, anorexia nervosa, or seizure disorders due to increased seizure risk
• Alcohol Warning: Avoid alcohol consumption while taking bupropion to reduce seizure risk
• Common Monitoring: Mood, blood pressure, sleep patterns, and potential anxiety symptoms
• Typical Supply: 90-day prescriptions with up to one year of refills

Understanding Off-Label Use

You might notice that neither medication is FDA-approved specifically for BED. This is completely normal and legal. Off-label prescribing means using an FDA-approved medication for a condition other than what it was originally approved for—and it’s extremely common in medical practice, particularly in psychiatry and eating disorder treatment.

In fact, clinical guidelines and research studies support using both topiramate and bupropion for BED. The only FDA-approved medication for BED is Vyvanse (lisdexamfetamine), a controlled stimulant that’s subject to much stricter telehealth prescribing rules. Many providers and patients prefer non-controlled options that can be more easily accessed via telehealth while still offering meaningful benefits.

Your provider should explain why they’re recommending a particular medication, the evidence supporting its use, potential benefits and risks, and alternatives. At Klarity Health, transparent communication is central to our approach—we believe you should understand exactly what you’re taking and why.

What to Expect During Your Telehealth Evaluation

The Initial Consultation

A legitimate telehealth evaluation for BED should be comprehensive, typically lasting 30-45 minutes for an initial appointment. Here’s what a quality evaluation includes:

Clinical Assessment:Your provider will ask detailed questions about your eating patterns, including:

• Frequency and nature of binge episodes
• Foods typically consumed during binges
• Feelings before, during, and after binges
• Whether you engage in compensatory behaviors (purging, excessive exercise, fasting)
• Impact on your daily life, relationships, and emotional wellbeing

Medical History Review:Expect questions about:

• Current medications and supplements
• Past medical conditions, especially seizure disorders, eating disorders, or mental health diagnoses
• Pregnancy status or plans
• Alcohol and substance use
• Family history of mental health or eating disorders
• Previous treatments you’ve tried

Mental Health Screening:Your provider should assess for co-occurring conditions like depression, anxiety, or ADHD, which frequently occur alongside BED.

Documentation and Verification:Reputable telehealth services will:

• Verify your identity and physical location (required in many states)
• Confirm they’re licensed in your state
• Obtain informed consent for telehealth treatment
• Document that you meet DSM-5 criteria for BED
• Create a detailed treatment plan in your electronic health record

Red Flags: If a service promises you a prescription before completing a thorough evaluation, or if the entire ‘appointment’ takes less than 10 minutes, that’s a major warning sign. Quality telehealth mirrors quality in-person care—shortcuts in evaluation lead to unsafe prescribing.

Treatment Planning Beyond Medication

While this article focuses on medication access, it’s important to note that evidence-based BED treatment typically involves multiple approaches. A quality provider will discuss:

• Cognitive Behavioral Therapy (CBT): The gold standard psychotherapy for BED
• Nutritional counseling: Working with a dietitian who specializes in eating disorders
• Support groups: Connecting with others who understand your experience
• Lifestyle modifications: Sleep, stress management, and movement that honors your body

Medication can be a valuable tool, but it works best as part of a comprehensive treatment approach. At Klarity Health, we emphasize whole-person care and can connect you with therapy and nutritional resources alongside medication management when appropriate.

Safety and Quality in Telehealth BED Treatment

How to Identify Reputable Providers

The telehealth landscape has evolved significantly since 2020, and not all services are created equal. Recent enforcement actions—like the indictment of executives from a telehealth startup for unsafe ADHD medication prescribing—have highlighted the importance of choosing legitimate providers.

Signs of Quality Telehealth Services:

✅ Thorough Evaluation Process: Initial appointments are substantive (30+ minutes) with comprehensive questions
✅ Licensed Providers: Clear information about provider credentials, specialties, and state licenses
✅ Transparent Pricing: Upfront costs with no hidden fees; acceptance of both insurance and self-pay options
✅ Proper Consent: Detailed telehealth consent forms explaining what telehealth can and cannot address
✅ Follow-Up Care: Scheduled monitoring appointments, not just one-and-done prescriptions
✅ Multi-Modal Treatment: Discussion of therapy, lifestyle changes, and alternatives to medication
✅ Pharmacy Coordination: Electronic prescriptions sent to standard pharmacies (CVS, Walgreens, etc.)—not shipped directly from the company

Red Flags to Avoid:

🚩 Guaranteed prescriptions before evaluation
🚩 No video consultation required (text-only services for psychiatric medications)
🚩 Extremely brief ‘consultations’ (under 10 minutes)
🚩 No discussion of side effects, contraindications, or alternatives
🚩 Medication shipped directly from the company rather than through a pharmacy
🚩 Aggressive marketing promising specific medications
🚩 No licensed provider name or credentials visible

Privacy and Security

Your telehealth provider must comply with HIPAA regulations, meaning:

• Secure, encrypted video platforms (not FaceTime or Zoom personal accounts)
• Protected electronic health records
• Secure prescription transmission to pharmacies
• Privacy practices clearly explained in writing

You have the right to know how your health information will be used and protected. Don’t hesitate to ask questions about data security.

Insurance, Pricing, and Accessibility

Does Insurance Cover Telehealth BED Treatment?

Medicare: As of 2025, Medicare continues to cover many telehealth services under temporary extensions, though specific medication coverage depends on your plan.

Private Insurance: Most major insurance plans now cover telehealth mental health and psychiatric services at the same rate as in-person visits. However, coverage varies by plan, so verify your benefits before starting treatment.

Medicaid: Coverage varies significantly by state. Some states have robust telehealth coverage while others remain more restrictive.

Cash-Pay Options

For those without insurance or who prefer not to use it, many telehealth services offer transparent self-pay pricing. At Klarity Health, we believe in price transparency—you’ll know exactly what you’ll pay before your appointment, with no surprise bills.

Cash-pay options often provide:

• More flexible scheduling (including evenings and weekends)
• Faster appointment availability
• Privacy from insurance records
• Competitive pricing often comparable to insurance copays

Medication Costs

The medications themselves are typically affordable:

• Generic topiramate: Often $10-30/month without insurance
• Generic bupropion: Usually $10-40/month without insurance
• Manufacturer coupons and pharmacy discount programs (like GoodRx) can reduce costs further

Brand-name versions (Topamax, Wellbutrin XL) cost more, typically $100-300/month without insurance, though rarely necessary.

Special Considerations and Contraindications

Who Should NOT Pursue Telehealth BED Treatment

While telehealth expands access, it’s not appropriate for everyone. You may not be a good candidate for online BED medication treatment if:

Active or Recent Purging Behaviors: If you have current bulimia nervosa or purge after binge eating, bupropion is contraindicated due to seizure risk. Your provider may recommend in-person eating disorder treatment programs instead.

Seizure Disorders: Both topiramate and bupropion affect seizure threshold. If you have epilepsy or a history of seizures, these medications require careful consideration and possibly in-person neurological evaluation.

Pregnancy or Breastfeeding: Topiramate carries significant pregnancy risks, including cleft palate. Most telehealth providers won’t initiate topiramate in pregnancy and will require effective contraception for women of childbearing potential.

Severe Medical Instability: If your eating disorder has caused acute medical complications (electrolyte imbalances, cardiac issues, severe malnutrition), you need in-person medical evaluation and monitoring.

Need for Higher Level of Care: Some individuals require intensive outpatient programs (IOP), partial hospitalization (PHP), or residential treatment. A thorough telehealth evaluation should identify when you need more intensive support.

Recent Substance Use Issues: Active alcohol or drug use, particularly stimulants or sedatives, may complicate medication management and require in-person addiction treatment.

Age Considerations

Most telehealth BED services focus on adults (18+). Adolescents with BED typically need specialized pediatric eating disorder care with parental involvement and often benefit from in-person family-based treatment approaches.

For young adults (18-25), providers should be especially vigilant about the antidepressant black box warning regarding suicide risk with bupropion and schedule closer follow-up monitoring.

Prescription Monitoring and Ongoing Care

No PMP Requirements for These Medications

Unlike controlled substances, non-controlled medications like Topamax and Wellbutrin don’t require checks of your state’s Prescription Drug Monitoring Program (PDMP) before prescribing. These databases track controlled substances to prevent ‘doctor shopping’ and inappropriate prescribing.

However, your provider may still:

• Ask about all current medications to check for interactions
• Review your medication history if you’re established in their system
• Request pharmacy records if there are concerns about overlapping treatments

This is good clinical practice, not a legal requirement.

Follow-Up Schedule

Expect regular monitoring, especially when starting medication:

First Month:

• Check-in at 1-2 weeks to assess tolerability and side effects
• Possible dose adjustment based on your response
• Monitoring for any concerning symptoms

Ongoing Care:

• Monthly or bimonthly appointments for the first few months
• Quarterly appointments once stable
• Annual comprehensive review (may satisfy state in-person requirements if done via video in most states)

Between Appointments:

• Many services offer secure messaging for non-urgent questions
• Clear protocols for urgent concerns or side effects
• Access to nursing staff or on-call providers

Refill Process

Because these are non-controlled medications, providers can typically issue:

• 90-day supplies with multiple refills
• Up to one year of refills in many states
• Automatic refill options through your pharmacy

However, continuing treatment requires periodic follow-up appointments. A prescription isn’t a ‘set it and forget it’ solution—BED is a complex condition requiring ongoing monitoring and adjustment.

Recent Regulatory Updates (2025-2026)

Federal Developments

DEA Telehealth Extensions: In January 2026, the DEA announced its fourth extension of COVID-era telehealth prescribing flexibilities for controlled substances through December 31, 2026. While this primarily affects stimulants and other controlled medications, it reflects the broader recognition that telehealth is here to stay.

Pending Permanent Rules: The DEA has been working on permanent telehealth prescribing regulations since 2023. The proposed ‘special registration’ system for telehealth prescribers of controlled substances remains in limbo, with implementation uncertain. These developments won’t affect non-controlled BED medications but signal the evolving landscape.

State Legislative Activity

New Hampshire (SB 252 – August 2025): Modernized telehealth law to explicitly allow prescribing of Schedule II-IV controlled substances via telehealth (with annual in-person follow-up), removing previous restrictions and aligning with federal flexibilities.

Wisconsin APRN Modernization Act (August 2025): Granted nurse practitioners full practice authority, allowing independent practice and prescribing without physician collaboration—significantly expanding provider availability for BED treatment.

Michigan Full Practice Authority (2025): Public Act 47 of 2023’s implementation in 2025 made Michigan a full-practice state for NPs, increasing the provider pool for mental health and eating disorder treatment.

California AB 1503 (2025): Expanded the definition of acceptable patient examinations to explicitly include asynchronous telehealth, making medication access even easier while maintaining care quality standards.

New York Final Rule (May 2025): Adopted in-person examination requirements for new controlled substance prescriptions (with exceptions), but explicitly exempted non-controlled medications—reinforcing that telehealth BED treatment remains fully accessible.

What This Means for Patients

The regulatory trend is clear: telehealth is becoming more established and accessible, not less. While there’s appropriate caution around controlled substance prescribing (particularly stimulants), non-controlled medications for conditions like BED continue to be readily available via legitimate telehealth services.

States are moving toward permanent telehealth frameworks rather than temporary emergency measures, providing stability and clarity for both providers and patients.

How Klarity Health Approaches BED Treatment

At Klarity Health, we’ve built our approach around what matters most to people seeking BED treatment: accessibility, transparency, and quality care.

Provider Availability

Our network includes:

• Board-certified psychiatrists
• Psychiatric nurse practitioners (in both collaborative and independent practice states)
• Providers with specialized training in eating disorders
• Evening and weekend appointment availability in most markets

Transparent Pricing

We believe you should never be surprised by healthcare costs:

• Clear pricing displayed before booking
• Acceptance of major insurance plans
• Competitive cash-pay rates for those without coverage or who prefer privacy
• No hidden fees or subscription traps

Comprehensive Care Model

While we can prescribe medication when clinically appropriate, we emphasize:

• Thorough evaluation (no prescription mills)
• Discussion of all treatment options, including therapy
• Connections to specialized eating disorder therapists
• Nutritional counseling referrals when helpful
• Ongoing medication management with regular check-ins

State-Specific Compliance

We ensure that:

• All providers are licensed in your state
• State-specific requirements (like periodic in-person visits) are clearly communicated
• Prescribing follows both federal and state regulations
• You understand any state-specific limitations before starting treatment

Taking the Next Step

If you’re considering telehealth treatment for Binge Eating Disorder, here’s how to move forward safely and effectively:

1. Self-Assess Your Readiness

• Are you experiencing binge eating at least weekly for several months?
• Have you tried other approaches (therapy, support groups, nutrition counseling)?
• Are you prepared for a comprehensive evaluation, not just a quick prescription?
• Do you have any contraindications (seizure history, pregnancy, active purging)?

2. Choose a Reputable Provider

• Research the service’s reputation and reviews
• Verify provider credentials and licensing
• Understand pricing before booking
• Ensure they offer ongoing care, not just one-time prescriptions

3. Prepare for Your Appointment

• List all current medications and supplements
• Document your eating patterns and binge frequency
• Note any previous treatments you’ve tried
• Prepare questions about side effects and expectations

4. Commit to the Full Treatment Process

• Medication is most effective combined with therapy and lifestyle changes
• Plan for regular follow-up appointments
• Monitor side effects and communicate with your provider
• Be patient—it typically takes 4-8 weeks to see meaningful improvement

5. Know When to Seek Higher-Level CareIf you experience:

• Suicidal thoughts or severe depression
• Dangerous weight loss or medical complications
• Inability to stop binge eating despite treatment
• Emergence of purging behaviors

…you may need more intensive treatment than telehealth alone can provide.

Conclusion: Telehealth Has Made BED Treatment More Accessible Than Ever

The combination of favorable federal regulations, progressive state laws, and expanded provider availability means that quality BED treatment via telehealth is both legal and accessible across the United States in 2025.

Medications like Topamax and Wellbutrin can be safely prescribed through comprehensive telehealth evaluations in all 50 states, with only a few requiring periodic in-person follow-up. The expansion of nurse practitioner practice authority has increased provider availability, while regulatory clarifications have given both providers and patients confidence in the legitimacy of telehealth mental health care.

However, accessibility shouldn’t come at the expense of quality. The most important factor in your treatment success isn’t just getting a prescription—it’s finding a provider who takes time to understand your unique situation, explains your options clearly, monitors your progress carefully, and connects you with additional resources when needed.

At Klarity Health, we’re committed to being that provider. Our platform combines the convenience of telehealth with the thoroughness and ongoing support you deserve, all at transparent prices whether you use insurance or pay out of pocket.

Ready to take the first step toward recovery from Binge Eating Disorder? Visit Klarity Health to schedule a comprehensive evaluation with a licensed provider in your state. You deserve accessible, quality care—and with telehealth, that care is now just a click away.

Research Currency Statement

Verified as of: January 4, 2026

DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.

States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025.

Sources Currency: 80%+ of sources are from 2025 (many late-2025) or updated to 2025.

Regulatory Status: Federal regulations for non-controlled substances remain stable. Temporary extensions for controlled substance telehealth prescribing continue through 2026 pending permanent DEA rulemaking.

References

1. HHS Press Room. (2026, January). DEA extends telemedicine prescribing flexibilities through December 31, 2026. U.S. Department of Health & Human Services. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Richter & Hampton LLP. (2025, August). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/

3. Center for Connected Health Policy. (2025, November). State telehealth laws and reimbursement policies: Online prescribing. https://www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide. (2025). State-by-state guide: Expanding roles for PAs and NPs (Updated 2025). https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. DailyMed. (2024). Bupropion hydrochloride extended-release tablets – FDA prescribing information. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12